Literature DB >> 2597432

Evaluation of antileishmanial activity of trans-aconitic acid.

S Misra1, T Sanyal, D Sarkar, P K Bhattacharya, D K Ghosh.   

Abstract

TAA, an inhibitor of the enzyme aconitase, inhibits the growth of L. donovani promastigotes. Morphogenic transformation of the amastigote to the promastigote (table; see text) form in vitro was also inhibited by 2 mM TAA. TAA also reduced multiplication of the parasite in macrophage culture. In the hamster model of leishmania, TAA significantly reduced the parasitic burden of liver. In acute toxicity tests with BALB/c mice no deaths were recorded even at a dose level of 2 g/kg body wt/day.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2597432     DOI: 10.1016/0885-4505(89)90052-2

Source DB:  PubMed          Journal:  Biochem Med Metab Biol        ISSN: 0885-4505


  4 in total

1.  Genetic and Biochemical Characterization of a Gene Operon for trans-Aconitic Acid, a Novel Nematicide from Bacillus thuringiensis.

Authors:  Cuiying Du; Shiyun Cao; Xiangyu Shi; Xiangtao Nie; Jinshui Zheng; Yun Deng; Lifang Ruan; Donghai Peng; Ming Sun
Journal:  J Biol Chem       Date:  2017-01-13       Impact factor: 5.157

2.  Experimental visceral leishmaniasis: role of trans-aconitic acid in combined chemotherapy.

Authors:  S Kar; K Kar; P K Bhattacharya; D K Ghosh
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

3.  In situ immunolocalization and stage-dependent expression of a secretory serine protease in Leishmania donovani and its role as a vaccine candidate.

Authors:  Rajdeep Choudhury; Partha Das; Siddhartha Kumar Bhaumik; Tripti De; Tapati Chakraborti
Journal:  Clin Vaccine Immunol       Date:  2010-01-27

Review 4.  Aconitic Acid Recovery from Renewable Feedstock and Review of Chemical and Biological Applications.

Authors:  Gillian O Bruni; K Thomas Klasson
Journal:  Foods       Date:  2022-02-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.